Adaptin Bio (APTN) Payables (2022 - 2026)
Adaptin Bio (APTN) posted Payables of $1.4 million for Q1 2026, down 9.31% sequentially from $1.5 million in Q4 2025, and up 319.29% YoY from $327057.0 in Q1 2025.
Adaptin Bio (APTN) Payables (2022 - 2026) Analysis & Trends
Adaptin Bio has reported Payables for 5 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Payables rose 319.29% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 319.29% YoY) and the FY2025 annual result came in at $1.5 million, down 20.67% from the prior year.
- Payables declined to $1.4 million in Q1 2026 per APTN's latest filing, from $1.5 million in the prior quarter.
- Over five years, Payables peaked at $1.9 million in Q4 2024 and troughed at $12804.0 in Q4 2022.
- A 5-year average of $646431.1 and a median of $258973.5 in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables jumped 2245.11% in 2024, then slipped 20.67% in 2025.
- Over 5 years, Payables stood at $12804.0 in 2022, then soared by 534.78% to $81277.0 in 2023, then surged by 2245.11% to $1.9 million in 2024, then slipped by 20.67% to $1.5 million in 2025, then slipped by 9.31% to $1.4 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 666,570.00 |
| Mar 31, 2025 | 327,057.00 |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 190,890.00 |
| Jun 30, 2024 | 165,489.00 |
| Mar 31, 2024 | 134,201.00 |
| Dec 31, 2023 | 81,277.00 |
| Sep 30, 2023 | 51,372.00 |
| Dec 31, 2022 | 12,804.00 |